Lamprecht Nanotherapeutics

Drug Delivery Concepts in Nanoscience
Erscheinungsjahr 2011
ISBN: 978-981-4241-16-8
Verlag: Pan Stanford Publishing
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 292 Seiten

This timely book provides an overview of possible therapeutic applications. The first part of the book highlights general properties of and phenomena observed with nanoparticles, and the subsequent consequences for applications in drug delivery. The second part focuses on the therapeutic approaches that are possible through the use of nanoparticles, with each chapter discussing a specific disease (e.g., diabetes, cancer, inflammation) and the relevant therapeutic approaches based on the design of nanoparticulate drug delivery systems. From this concise book, readers will gain an insight into the basics of nanoparticle preparation and find a more detailed account of what is therapeutically feasible by using nanoparticle approaches.

Zielgruppe

Academia and research laboratories in the biomedical and pharmacological fields. Useful for postgraduate students and researchers in the pharmaceutical industry.

Autoren/Hrsg.

Lamprecht, Alf

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
• Technische Wissenschaften Technik Allgemein Nanotechnologie

Inhaltsverzeichnis

General Aspects in Nanoparticulate Drug Delivery: Nanoparticles
Transport Phenomena on Biological Barriers
Drug Targeting Approaches
Gene Therapy
Therapeutic Approaches for Various Diseases: Cancer
Immunologic Approaches
Inflammatory Diseases
Diabetes
Brain Diseases
Skin Diseases
Antibiotics
Parasitology
Vaccination

Über Autor(innen)

Alf Lamprecht studied pharmacy at the Saarland University in Saarbrucken, Germany, where he also received his PhD in 2001. After postdoctoral fellowships at the University of Angers, France, and the Gifu Pharmaceutical University, Japan, he was appointed assistant professor at the University of Nancy, France, before he became professor of pharmaceutical engineering at the University of Franche-Comté in Besancon, France, in 2005.

He is a member of the Controlled Release Society (CRS), the American Association of Pharmaceutical Sciences (AAPS), the German Pharmaceutical Society (DPhG) and Academy of Pharmaceutical Science and Technology, Japan (APSTJ). He serves as a member of the editorial board of Drug Development and Industrial Pharmacy. He received the Carl Wilhelm Scheele Prize of the German Pharmaceutical Society (DPhG) in 2001 and the Krka Award (Slovenia) and Eduard-Martin Award (Germany) in 2002.